{
  "treatment_arm_id": "APEC1621-F",
  "name": "APEC1621-F",
  "version": "2015-08-06",
  "stratum_id": "100",
  "date_created":"2017-02-22",
  "treatment_arm_status": "OPEN",
  "assay_rules": [{
    "type":"IHC",
    "gene" : "PTEN",
    "assay_result_status" : "NEGATIVE",
    "assay_variant" : "PRESENT",
    "level_of_evidence" : 3.0
  }],
  "study_id": "APEC1621",
  "num_patients_assigned": null,
  "treatment_arm_drugs": [{
    "name": "Crizotinib",
    "pathway": "ALK",
    "drug_id": "113"
  }],
  "snv_indels": [{
    "variant_type": "snp",
    "chromosome": "chr2",
    "position": "252419923",
    "identifier": "pedmatch-2",
    "ocp_reference": "A",
    "ocp_alternative": "C",
    "level_of_evidence": 3.0,
    "inclusion": true,
    "armSpecific": false
  }],
  "gene_fusions":[],
  "non_hotspot_rules": [],
  "copy_number_variants": [],
  "diseases": [{
    "disease_code_type":"ICD-O",
    "disease_code": "10058354",
    "disease_name": "Bronchioloalveolar carcinoma",
    "exclusion":true
  }],
  "exclusion_drugs": [{
    "name": "Doxorubicin Hydrochloride",
    "drug_id": "10001",
    "drug_class": "ALK inhibitor",
    "target": "ALK"
  }]
}